Developing World Diseases
Part of the Novartis Institutes for Developing World Medical Research (NIDWMR)
Novartis fosters collaboration and accesses talent pools throughout the world. NIBR works to contribute drugs and vaccines for neglected diseases through drug discovery and vaccine research at NITD and NVGH; contributes to new therapeutic targets, technologies and drug discovery through GNF; and contributes to the discovery of the basic molecular mechanisms of cells and organisms in health and disease through FMI.
The Novartis Institute for Tropical Diseases ›
Aims to discover novel treatments and prevention methods for major tropical diseases and contributes to education by its teaching and training opportunities
The Novartis Vaccines Institute for Global Health ›
Focusing on diseases that are not receiving adequate attention
Our success depends on the creativity and performance of our associates.
Novartis operates in 140 countries around the world.